TPD & Induced Proximity Summit Leaderboard
  • Monday, June 29, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 211

Author

Pharma Journalist 8903 posts 0 comments

Sobi Receives Approval from Health Canada for Empaveli (pegcetacoplan) for the Treatment of Certain…

Dec 12, 2022
Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB, announced that Health Canada has approved Empaveli™ (pegcetacoplan), a complement inhibitor, for the…
Read More...

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted…

Dec 9, 2022
Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine…
Read More...

Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape…

Dec 9, 2022
Vertex Pharmaceuticals Incorporated and Entrada Therapeutics, Inc. announced a global collaboration focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV™)…
Read More...

Reuters Events Digital Health event returns to California to help empower clinicians, engage…

Dec 9, 2022
300+ C-suite and board level leaders from NYU Langone, Sutter Health, Memorial Hermann, UCI Health and others will unite in San Diego on May 16-17, to force radical change over two…
Read More...

Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH

Dec 8, 2022
Akero Therapeutics, Inc. a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, announced that…
Read More...

VBI Vaccines Announces Health Canada Approval for PreHevbrio for the Prevention of Hepatitis B in…

Dec 8, 2022
VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, announced that Health Canada has approved PreHevbrio…
Read More...

Touchlight and Odimma Therapeutics Announce Clinical Material Supply Agreement to Develop…

Dec 8, 2022
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, announces a development and supply agreement with Odimma Therapeutics, a French…
Read More...

Novavax Nuvaxovid COVID-19 Vaccine Approved in Canada for Use as a Primary Series in Adolescents

Dec 8, 2022
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Health Canada has approved a…
Read More...

Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like…

Dec 8, 2022
Pfizer Inc. and Clear Creek Bio, Inc. announced a research collaboration and exclusive license agreement to advance the discovery and development of potential inhibitors of the…
Read More...

Kite and Daiichi Sankyo Announce Changes to YESCARTA CAR T-Cell Therapy Licensing Agreement in Japan

Dec 8, 2022
Kite Pharma, Inc., a Gilead Company, (hereafter Kite) and Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo) jointly announced the revision of their 2017 partnership agreement, which…
Read More...
Prev Next
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • AstraZeneca, YMCA Launch National Cancer Education Partnership
  • Antares, Novartis Partner on Cancer Drug Discovery
  • FDA Approves TRYNGOLZA for Severe Hypertriglyceridemia
  • RQ Bio Raises $115 Million for Influenza Antibody Therapy
  • EU Approves KEYTRUDA-Padcev for Bladder Cancer

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.